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Obesity and associated metabolic diseases are sexually
dimorphic. To provide better diagnosis and treatment for both
sexes, it is of interest to identify the factors that underlie male/
female differences in obesity. Traditionally, sexual dimorphism
has been attributed to effects of gonadal hormones, which
influence numerous metabolic processes. However, the XX/XY
sex chromosome complement is an additional factor that may
play a role. Recent data using the four core genotypes mouse
model have revealed that sex chromosome complement—
independently from gonadal sex—plays a role in adiposity,
feeding behavior, fatty liver and glucose homeostasis. Potential
mechanisms for the effects of sex chromosome complement
include differential gene dosage from X chromosome genes
that escape inactivation, and distinct genomic imprints on X
chromosomes inherited from maternal or paternal parents.
Here we review recent data in mice and humans concerning
the potential impact of sex chromosome complement on
obesity and metabolic disease.

Hormonal and Genetic Factors Contribute
to Sex Differences
Obesity and the metabolic syndrome are complex diseases regulated by many genetic and environmental factors. It is well known
that risk, development and manifestations of obesity-related
conditions such as diabetes and atherosclerosis are sexually
dimorphic. Sex differences in obesity are strongly influenced by
gonadal hormone effects.1,2 However, an additional fundamental
difference that may contribute to metabolic differences between
females and males lies within the nucleus of each cell—the XX
and XY sex chromosome complement.
The sex chromosome complement of female and male cells
imposes several known genetic differences3 (Fig. 1). For example,
female cells with an XX chromosome complement never express
any of the 78 protein-coding genes, nor an unknown number
of noncoding RNAs, that are present on the Y chromosome. In
addition, only XX cells undergo the process of transcriptional
inactivation of one of the two X chromosomes during early development as a mechanism to balance gene dosage between males
and females.4-6 X chromosome inactivation involves the expression
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of X chromosome noncoding RNAs, production of high levels
of histones, widespread chromatin remodeling and chromosome
condensation, such that XX cells experience a distinct nuclear
microenvironment during this process.4 Furthermore, whereas
XY cells inherit only a maternally imprinted X chromosome,
XX cells carry one X chromosome with maternal imprints and
another with paternal imprints.5 The random inactivation of
one X in XX cells therefore could lead to differential expression
of imprinted genes compared with XY cells. Finally, although
X-inactivation silences most genes on one X chromosome, some
genes escape this process and are expressed at a higher level in
tissues of females than males.6-8
In humans and standard animal models, it has been difficult to distinguish the contributions of gonadal hormones and
sex chromosome complement as determinants of obesity, since
female gonads are virtually always present in combination with
XX chromosomes, and male gonads with XY chromosomes. To
tease apart the influence of sex chromosome complement from
gonadal hormones in obesity and related metabolic traits, we
have used the four core genotypes mouse model.9,10 In this model,
the testis-determining gene, Sry, is deleted from the Y chromosome and an Sry transgene is inserted into an autosome. Thus,
the Y chromosome segregates independently from the Sry gene
and formation of male gonads. As a result, this model allows
the generation of mice with four different “sexes” on a C57BL/6
background: XX mice with either male or female gonads, and
XY mice with either male or female gonads (Fig. 2). In addition,
we gonadectomized these mice to remove acute gonadal hormone action and uncover the effects of sex chromosome complement, as well as to detect long-lasting (organizational) effects of
gonadal hormones.
In our recent study,11 we observed dramatic effects of sex chromosome complement on obesity and metabolism (summarized
in Fig. 3). Male and female mice with two X chromosomes had
higher body weight and nearly twice as much body fat than mice
with one X and one Y chromosome. XX mice also had increased
food intake during the light (inactive) phase of the circadian
cycle, potentially contributing to their higher body weight. When
placed on a high fat diet, XX mice gained weight at an accelerated
pace, and developed fatty liver and insulin resistance. A potential
mechanism may be that genes escaping X-inactivation drive these
differences observed between XX and XY mice. In support of
this, we observed increased expression of X-inactivation escapees
in key metabolic tissues (adipose and liver) of XX mice. In this
article, we discuss these findings in the context of other reported
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sex differences in obesity, metabolic dysregulation, circadian rhythms and food intake.
Sex Chromosomes Influence
Obesity and Associated Metabolic
Dysregulation
The sexually dimorphic nature of human
adipose tissue content and anatomical distribution has been widely documented and
reviewed in recent excellent review articles.12,13 It is well known that pre-menopausal
women tend to store fat in subcutaneous
depots, while men tend to store fat in visceral depots. After menopause, women begin
to accumulate fat in the viscera, commonly
associated with increased risk for metabolic
diseases such as type 2 diabetes, non-alcoFigure 1. Genetic and epigenetic consequences of sex chromosome complement. XX cells
holic fatty liver disease and atherosclerosis.
undergo X inactivation, which requires cellular resources to produce histones and non-coding
These differences in fat distribution have
RNAs. Some genes escape X inactivation and are expressed at a higher level in XX compared
with XY cells. Additionally, differential genomic imprinting (silencing) of genes on the X chrobeen attributed largely to the acute action
mosome inherited from maternal and paternal parents can lead to gene dosage differences in
of circulating sex hormones. Studies in the
XX cells and XY cells.
four core genotypes mouse model described
above, however, revealed that sex chromosome complement also influences adiposity
showed a similar degree of steatosis in males and females, but
and metabolism.
In gonadally intact mice of the four core genotypes, both greater inflammation in females.18 The different diets used in
gonadal sex and sex chromosome complement had effects on each of these rodent studies make it difficult to make comparibody weight.11 Gonads were subsequently removed in adulthood, sons and firm conclusions. However, the results in Chen et al.11
thus eliminating acute effects of gonadal hormones. XX mice fed strongly suggest that sex chromosome complement may be an
a standard mouse chow diet (~5% fat) had almost double the fat underlying determinant of hepatic steatosis that should be conmass of XY mice, regardless of their original gonadal sex. When sidered in studies of rodents and humans.
the mice were fed a high fat diet after gonadectomy, the differAnother typical feature of obesity is insulin resistance. In
ence between XX and XY mice was amplified, with XX mice the four core genotypes model, the high fat diet did not alter
gaining weight more rapidly, and diverging from XY mice after glucose levels, but induced a 2-fold elevation in fasting insulin
only three days on the high fat diet. Analysis of specific fat depots levels in XX mice, but not XY mice.11 Thus, XX chromosome
revealed that XX mice had larger subcutaneous inguinal adipose complement appears to be a risk factor for insulin resistance
tissue depots, whereas XY mice had larger gonadal fat pads. This in this model. Interestingly, studies in humans show that preresult suggests that sex chromosome complement is a contribut- menopausal women are more insulin sensitive than men.19-21 This
ing factor to the differences in fat distribution that are observed may be due to the positive effects of estrogen and/or the negative
between females and males.
effects of androgens on insulin sensitivity.22 Thus, while gonadal
Obesity causes many complications in tissues other than adi- hormones clearly play a significant role in insulin signaling, our
pose, such as ectopic accumulation of fat in the liver. In addition work shows that having two X chromosomes may be an addito the increased adiposity in XX mice, a high fat diet promoted tional genetic determinant, and may become most relevant in a
lipid droplet accumulation in livers of XX mice, whereas XY mice hypogonadal state, such as after menopause.
were virtually protected.11 This was reflected in increased liver
mass, increased hepatic triglyceride levels and reduced fatty acid
Determinants of Sex Differences in Food Intake
oxidation gene expression in XX mice compared with XY mice.
and Circadian Rhythms
These results implicate sex chromosome complement as a risk
factor for fatty liver. Epidemiological data in humans also show To understand why XX mice accumulate more adipose tissue
that sexual dimorphism exists in susceptibility to non-alcoholic than XY mice, Chen et al.11 assessed energy expenditure, physical
steatohepatitis, but some populations exhibit increased incidence activity, and food intake at a point when body weights among
in women, while others report increased incidence in men.14-16 the four genotypes were the same (four weeks post-gonadecData in rodents are also contradictory. Male rats fed a methio- tomy). No differences were detected in energy expenditure or
nine-choline-deficient diet develop more severe hepatic steatosis activity among the genotypes, but XX mice exhibited increased
than females,17 whereas C57BL/6J mice fed a high fructose diet food intake. This was notable because it occurred prior to their
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Figure 2. The four core genotypes mouse model. This mouse model
generates four different “sexes”: mice with female gonads that have
either XX or XY sex chromosomes, and mice with male gonads that
have either XX or XY sex chromosomes. Differences between gonadal
females and gonadal males are attributed to acute or organizational
gonadal hormone effects, while differences between XX and XY mice
are attributed to the sex chromosome complement.

Figure 3. Metabolic impact of two X chromosomes. Mice with two X
chromosomes have a higher food intake during the inactive phase,
higher body weight and greater adipose tissue content. When placed
on a high fat diet, these mice exhibit rapid weight gain and develop
insulin resistance and fatty liver.
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divergence from XY mice in body weight, and therefore may be
a causative factor in the subsequent increased adiposity in XX
mice. It was also notable that the increased food intake occurred
exclusively during the light phase, during which mice (which
are nocturnal) have reduced activity and typically consume only
about 30% of their daily food. The increased food intake during
the light phase raises the intriguing possibility that sex chromosome complement influences circadian regulation.
There is increasing evidence in mice and humans that disruption in the circadian cycle affects eating patterns and may
contribute to obesity.23,24 The distribution of caloric intake
throughout the day is an important factor in human obesity.25
In particular, eating during the inactive phase of the circadian
cycle, such as midnight snacking, is associated with weight gain
and greater risk of the metabolic syndrome.26-28 Genetic disruption of the circadian cycle by mutation of the mouse Clock gene,
a central transcriptional regulator of circadian rhythm, causes
increased feeding during the light (inactive) period and obesity.29
Furthermore, wild-type mice that eat on a circadian-shifted
schedule are also prone to obesity. For example, when mice were
fed equivalent amounts of a high fat diet exclusively during the
dark phase or exclusively during the light phase, those who ate
during the light phase gained double the weight, despite similar
activity levels.30 Additional studies of light-restricted feeding in
mice have also shown increased weight gain, as well as altered
metabolic gene expression in fat and liver, and higher respiratory
exchange ratio, indicating reduced reliance on fatty acid oxidation.31,32 Interestingly, the increased adiposity in XX mice in the
study by Chen et al.11 was associated with altered metabolic gene
expression and higher respiratory exchange ratio. The mechanisms for the increased weight gain with disruption of circadian
rhythm are not well understood, but may depend on a rhythmic
profile of leptin levels that normally occurs throughout the circadian cycle.33 It will be interesting to determine whether altered
rhythmicity of leptin, or perhaps leptin resistance, is present in
XX compared with XY mice, and whether limitation of feeding
in XX mice to the dark period may alleviate the increased weight
gain.
Sexual dimorphism in eating behavior of male and female
rodents has been described, and gonadal hormones have been
implicated. Several studies show that food intake and satiety are
highly regulated by estradiol.34 In gonadally intact female rats,
a rise in estradiol secretion is followed by a reduction in food
intake, whereas ovariectomy results in increased food intake.
Furthermore, estradiol interacts with other satiety signals in the
central nervous system and in the periphery.34 It has also been
shown that female rats that have been fasted for 48 h activate
orexin neurons (which promote feeding) to a greater extent and
consume more food than males.35 Nevertheless, the data in Chen
et al.11 showing that gonadectomized mice with XX chromosomes eat more than XY mice reveals that additional genetic factors beyond gonadal hormones also contribute to sex differences
in food intake and meal patterns. The four core genotypes mouse
model provides a tool to further dissect the effects of gonadal
hormones and sex chromosome effects on feeding behavior and
metabolic disease.
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Relevance to Humans
With the increasing longevity of humans and thus a longer time
spent in a hypogonadal state, it is important to understand nonhormonal regulators of sexual dimorphism. Chen et al.11 demonstrated that the sex chromosome complement is an important
determinant of adiposity, fatty liver, and insulin levels in the
absence of sex hormones. These results in the mouse raise the
question of whether sex chromosome aneuploidies in humans
might be instructive about the role of sex chromosomes in metabolic regulation. Human sex chromosome aneuploidies include
45,X0 females (1/2,500 live female births), 47,XXY males
(1/500 live male births), 48,XXYY (1/17,000 live male births),
48,XXXY males (1/50,000 live male births), and 46,XX males
(1/20,000 live male births, resulting from translocation of the
SRY gene to the X chromosome).36-38 The rarity of most sex chromosome aneuploidies has made it difficult to assess their effects
on metabolism. However, some data available for XXY males and
X0 females indicate higher incidence of metabolic disease than
the general population, as described below.
Compared with XY males, individuals with Klinefelter syndrome (XXY) are more likely to have an atherogenic lipoprotein profile, with elevated low density lipoprotein levels, and
reduced high density lipoprotein levels.39 XXY men may also
have increased incidence of type 2 diabetes and metabolic syndrome, defined as the co-occurrence of visceral obesity, insulin
resistance and enhanced cardiovascular disease risk.40,41 These
findings in XXY men are consistent with mouse studies in which
the presence of two X chromosomes compared with a single X
was associated with obesity and metabolic dysregulation.11 XXY
men have lower levels of testicular androgens, which could contribute to the metabolic effects associated with the syndrome, so
it is unclear which factors are the most important.
Turner syndrome women (X0) tend to have greater fat mass
when adjusted for body weight than XX females.42,43 X0 women
may also experience increased risk for type 2 diabetes mellitus
and heart disease.44 These results appear to contradict the finding in mice that presence of one X chromosome leads to reduced
adiposity compared with XX mice.11 One factor that potentially
contributes to increased metabolic dysregulation in Turner syndrome women is that they are hypogonadal throughout their
lifetime. In contrast, in the mouse studies, animals had intact,
normal gonads until adulthood and therefore may have experienced critical activational and organizational effects of gonadal
hormones that are metabolically beneficial and not experienced
by X0 humans. Interestingly, an analysis of body fat and lipid
levels in a group of Turner syndrome patients showed differences
depending on the parental origin of the single, normal X chromosome. Individuals that inherited the maternal X chromosome
had 78% more visceral fat than those carrying an X chromosome of paternal origin, and higher triglyceride and low density lipoprotein cholesterol levels.45 The maternal and paternal
X chromosomes carry distinct genomic imprints, which silence
the expression of specific genes and result in different expression levels. These results dovetail with those in the mouse showing that X chromosome dosage influences metabolic regulation,
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and highlight the mechanism of differential imprinting of the
X chromosome from the two parents as a potential contributing
mechanism.
Future Perspectives
Sexual dimorphism is a critical component that affects numerous aspects of metabolism and, hence, susceptibility to metabolic
disease. The pervasive effect of sex on metabolism is strikingly
illustrated by a recent metabolomic study of serum from more
than 3,000 men and women.46 An unbiased analysis of 131 blood
metabolites (including amino acid, fat and sugar molecules)
revealed significant concentration differences between males and
females for 102 of the metabolites. Thus, widespread differences
in metabolism clearly occur in males and females, and there is a
need to better understand the nature and origin of these for effective treatment of metabolic diseases in both sexes.
Studies in humans are valuable, and every effort should be
made to perform well-designed, sufficiently powered studies of
both sexes. But such studies will always be limited in their ability
to provide insight into the underlying mechanisms for sex differences, and it is in this realm that animal models are critical.
The four core genotypes mouse model is one such model and
is unique in that it allows the discrimination of effects due to
gonadal sex or sex chromosome complement.10 Based on the initial identification of sex chromosome effects on adiposity, feeding
behavior, fatty liver and insulin resistance, we anticipate that this
model will be useful to provide additional insight into the genetic
factors and physiological mechanisms involved. As presented
in Chen et al.,11 genes that escape X chromosome inactivation
exhibit increased expression levels in tissues such as adipose and
liver, which may lead to phenotypic differences. In addition to
the expression of protein coding genes examined thus far, additional potential players include long non-coding RNAs that are
known to escape X-inactivation,8 and potentially some of the 70
microRNAs that are present on the X chromosome, which have
not been assessed for potential inactivation escape.
A valid question is whether results obtained in a model such
as the four core genotypes mouse will translate to humans.
Several factors suggest that they will. The genes on the human
and mouse X chromosomes are highly conserved, as is the process of X chromosome inactivation. Furthermore, the genes
that are known to escape inactivation in the mouse also escape
inactivation in humans.47 Additional genes have also been
shown to escape X-inactivation in humans, suggesting that sex
chromosome effects may potentially be amplified in humans
compared with mice.48 And finally, in the mouse studies, sex
chromosome effects were most apparent in mice that had been
gonadectomized as adults. Although humans are not typically
gonadectomized, both women and men experience periods of
hypogonadal hormone levels, typically beginning in middle age.
It is likely that the sex chromosome effects observed in mice
may become more influential in humans with advancing age,
which is when the majority of individuals develop metabolic
diseases such as type 2 diabetes and cardiovascular disease.
It will be interesting to determine the effects on obesity and
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dysregulated metabolism when gonadectomy is performed in
four core genotype mice at advanced ages, to better parallel the
onset of menopause in humans. Moreover, mouse models offer
considerable advantages for identifying the X gene(s) responsible for the sex chromosome effect, which can then be tested
in studies of humans. Ultimately, the identification of genes or
factors that promote or protect against metabolic diseases in a
sex-specific manner may suggest novel pathways as targets for
therapeutic intervention.
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